Navigation Links
Embla Systems in Collaboration with Beth Israel Deaconess Medical Center to Develop Cardio-Pulmonary Coupling Technology
Date:12/13/2007

DENVER, Dec. 13 /PRNewswire/ -- Embla Systems, a leader in the field of sleep diagnostic software and equipment announced today the signing of an exclusive agreement with the Beth Israel Deaconess Medical Center (BIDMC) for the distribution of the Cardio Pulmonary Coupling (CPC) technology developed by Drs. Robert Thomas, Ary Goldberger, C-K. Peng, and Mr. Joseph Mietus.

CPC technology represents a breakthrough in how sleep can be visualized, by presenting a simple and accurate picture of sleep oscillations and interactions instead of the tedious manual sleep stage scoring and counting of respiratory events that has been the standard for the last 40 years. The analysis has been validated using over 10,000 sleep studies. "The CPC technology is not a sleep-stage or respiratory event detector but [it] does provide a dynamic measure of sleep state-modulated cardio-pulmonary interactions," says Dr. Robert Thomas. "As the technique is automated, inter-scorer reliability is eliminated as a problem. The technique can track dynamic sleep physiology, and provide a unique ambulatory measure of sleep quality."

"With the anticipated introduction of reimbursement for home testing, the integration of this technology into Embla's existing product line confirms our dominant position in this market place," said David Baker, President and CEO of Embla. "In addition, the technology will allow us to develop very low cost and reliable diagnostic tools to assist clinicians in diagnosing the presence of sleep apnea among the huge population of undiagnosed people who suffer from this condition, while allowing an unprecedented method to monitor treatment effects on sleep quality and respiratory dynamics in the 13 million or so users of CPAP machines in the US alone".

The CPC technology will give physicians the "Sleep Health" of a patient and to evaluate if the patient has Obstructive, Central or Complex Sleep Apnea. The clinical significance of such a simple and l
'/>"/>

SOURCE Embla Systems
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
2. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
3. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. NxStage Medical Provides Update on Medisystems Acquisition
6. ICx Awarded $1.5 M Contract by Department of Homeland Security for Development of Next Generation Bio Aerosol Systems
7. Imaging Diagnostic Systems New Laser Breast Imaging Scanner Introduced in Malaysia
8. Varian Medical Systems Exhibits Latest Technologies and Products Designed to Improve Speed and Precision of Radiotherapy at ESTRO 2007
9. Biomaxx Systems Inc. Selected as Technical Consultant By Southern Cross Agricultural Developments
10. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
11. Ingenuity Systems Joins Biomarkers Consortium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... 16, 2015 OncoTAb, Inc., ... (UNC Charlotte) spin-out company, announced today the appointment ... M.D., as Chief Operating Officer (COO). Cooper brings ... in developing clinical diagnostic and biotechnology platforms in ... , Cooper’s extensive career transcends the field of ...
(Date:4/16/2015)... April 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... U.S. joint venture with G-treeBNT (ReGenTree LLC) has ... clinical trial for the orphan disorder, neurotrophic keratopathy ... dry eye syndrome (DES) in the U.S.  Both ... RGN-259/GBT201, this year.  Each of these eye disorders ...
(Date:4/16/2015)... DIEGO , April 16, 2015  AnaptysBio, ... development of therapeutic antibodies, today announced the ... antibody program into IND-enabling studies. The Company,s ... novel treatment for generalized pustular psoriasis (GPP), ... unmet medical need. ANB019 is wholly owned within ...
(Date:4/16/2015)... Switzerland , April 16, ... part of Debiopharm Group ™ , a Swiss-based ... target unmet medical needs as well as ... on the investigational compounds Debio 1143 (SMAC mimetic) ... presented at the 2015 Annual meeting of ...
Breaking Biology Technology:OncoTAb Names Dr. David L. Cooper as COO 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3
... CARLOS, Calif., Dec. 2 SleepQuest is proud to ... Joint Commission on the,Accreditation of Health Care Organizations (JCAHO) ... and safety. , ... of,national standards by The Joint Commission,s home care service ...
... Martek Biosciences Corporation (Nasdaq: MATK ) announced that it ... year 2008 on December 11, 2008, at approximately 4:00 p.m. Eastern ... will conduct a conference call to discuss these results with investors. ... webcast by visiting Martek,s web site at http://investors.martek.com . , ...
... On Track to File NDA with FDA in Early ... WOODCLIFF LAKE, N.J., Dec. 2 Strativa Pharmaceuticals, the ... PRX ) today announced that its development ... pivotal bioequivalence studies for a thin film formulation of ...
Cached Biology Technology:SleepQuest Achieves Coveted Accreditation 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 3Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 4
(Date:4/2/2015)... 2, 2015 According to preliminary ... to somewhat higher than 125 MSEK. This exceeds the ... 2014 that revenues for Q1 2015 would be in ... for Q4 2014. The operating result for the first ... complete interim report will as previously communicated be published ...
(Date:3/31/2015)... March 31, 2015   Guidepoint , a leading ... the Post-Surgical Pain Management TRACKER, part of the ... trends in the medical device and therapeutics markets. The ... including treatment volumes, market share, and adoption rates across ... with joint surgery. The Post-Surgical Pain Management ...
(Date:3/24/2015)... NexID Biometrics LLC, whose spoof-mitigation technology boosts protection ... beginning of shipments of version 2.0 of its industry ... in Potsdam, N.Y. , is making ... here today at the Walter E. Washington Convention Center. ... boosts the accuracy rate range to 96.5 to 99.5 ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2
... release is available in German . ... that show a huge improvement in the light absorption ... This has been achieved by applying atomic layer coating. ... high sensitivity light response such as high efficiency solar ...
... in Earth,s climate from more than 100,000 years ago indicates ... previously thought and may be a good analog for future ... temperatures rise. The research findings also indicate that ... contributed more to sea-level rise at that time than melting ...
... The iconic salt marshes of the famous summer retreat ... the most popular recreational areas. The erosion is a ... Great Depression-era ditches constructed by Works Progress Administration (WPA) ... ecological cause and effect is described by Tyler Coverdale ...
Cached Biology News:Analysis of Greenland ice cores adds to historical record and provide glimpse into climate's future 2Analysis of Greenland ice cores adds to historical record and provide glimpse into climate's future 3Analysis of Greenland ice cores adds to historical record and provide glimpse into climate's future 4Depression-era drainage ditches emerge as sleeping threat to Cape Cod salt marshes 2Depression-era drainage ditches emerge as sleeping threat to Cape Cod salt marshes 3Depression-era drainage ditches emerge as sleeping threat to Cape Cod salt marshes 4
... The Jouan RC Maxi MB (for ... of vacuum concentrator/centrifugal evaporator systems respond to ... for rapid and safe concentration of heat-labile ... with pumps, different of cold traps and ...
... Jouan RC10 series of vacuum concentrators/centrifugal evaporators ... features allied to rapid and safe concentration ... be combined with oil-free or high vacuum ... a wide selection of rotors (eliminating sample ...
... RC Standard MB (For small quantities of ... samples) of vacuum concentrator/centrifugal evaporator systems respond ... biochemistry for rapid and safe concentration of ... expanded with pumps, different of cold traps ...
The PxE Thermal Cycler (PxE) is a licensed 96 well PCR machine, developed to provide all fundamental features for value for money thermal cycling....
Biology Products: